Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Wilson DE, et al. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127: 820-823, 1968. PubMed: 5651140, RefSchmeding KA, et al. Sexual compatibility between serotypes of Filobasidiella neoformans (Cryptococcus neoformans). Curr. Microbiol. 5: 133-138, 1981. , RefEvans EE. An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytical). Proc. Soc. Exp. Biol. Med. 71: 644-646, 1949. Wilson DE, et al. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127: 820-823, 1968. PubMed: 5651140
Schmeding KA, et al. Sexual compatibility between serotypes of Filobasidiella neoformans (Cryptococcus neoformans). Curr. Microbiol. 5: 133-138, 1981.
Evans EE. An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytical). Proc. Soc. Exp. Biol. Med. 71: 644-646, 1949.
Fan M, et al. The 5S rRNA and the rRNA intergenic spacer of the two varieties of Cryptococcus neoformans. J. Med. Vet. Mycol. 33: 215-221, 1995. PubMed: 8531018
Belay T, et al. Serotyping of Cryptococcus neoformans by dot enzyme assay. J. Clin. Microbiol. 34: 466-470, 1996. PubMed: 8789042
Nussbaum G, et al. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice. Infect. Immun. 67: 4469-4476, 1999. PubMed: 10456888
Wilson DE, et al. Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127: 820-823, 1968. PubMed: 5651140
Schmeding KA, et al. Sexual compatibility between serotypes of Filobasidiella neoformans (Cryptococcus neoformans). Curr. Microbiol. 5: 133-138, 1981.
Evans EE. An immunologic comparison of twelve strains of Cryptococcus neoformans (Torula histolytical). Proc. Soc. Exp. Biol. Med. 71: 644-646, 1949.
